By contrast, increased ChREBP expression levels in response to mitogenic stimulation, as well as in various tumors, including prostate and breast cancers, suggest that ChREBP signaling may be activated during carcinogenesis46,70,71. The gene discussed is MLXIPL; the disease is breast carcinoma.